SCHEMBL30121075

SCHEMBL30121075

Cc1cc(-c2c(C(C)C)nc([N+]34CCN(CC3)CC4)c3cc(OCc4ccccc4)ccc23)ccc1F

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR3 Q99500 1/20 0.36
HRH3 Q9Y5N1 3/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
NPC1 O15118 3/20 0.36
RAB9A P51151 3/20 0.36
MAPT P10636 1/20 0.33
KDR P35968 1/20 0.33
WDR5 P61964 1/20 0.33
ALOX5 P09917 1/20 0.33
DRD2 P14416 1/20 0.33
HTR6 P50406 1/20 0.33
PKM P14618 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
MAOA P21397 1/20 0.32
MAOB P27338 1/20 0.32
CASP3 P42574 1/20 0.32
SENP8 Q96LD8 1/20 0.32
SENP7 Q9BQF6 1/20 0.32
SENP6 Q9GZR1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23887866 1.00 S1PR3 (0.36) S1PR3HRH3MEN1KMT2ANPC1
SCHEMBL23887854 0.90 HRH3 (0.38) S1PR3HRH3MEN1KMT2ANPC1
SCHEMBL23887843 0.88 HRH3 (0.38) S1PR3HRH3MEN1KMT2AMAPT
SCHEMBL25557296 0.86 HRH3 (0.38) HRH3MEN1KMT2ANPC1RAB9A
SCHEMBL23887776 0.83 FFAR1 (0.37) MEN1KMT2ANPC1RAB9AMAPT
SCHEMBL25544258 0.82 GCGR (0.31)
SCHEMBL23896099 0.82 ALOX5 (0.38) S1PR3MEN1KMT2ANPC1RAB9A
SCHEMBL23896020 0.80 HSD17B10 (0.43) MEN1KMT2ARAB9AMAPTKDR
SCHEMBL25555406 0.79 ALOX5 (0.43) S1PR3MEN1KMT2ANPC1RAB9A
SCHEMBL23887860 0.75 PARP14 (0.36) S1PR3EDNRBEDNRAFFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4126819-A1 7- OR 8-HYDROXY-ISOQUINOLINE AND 7- OR 8-HYDROXY-QUINOLINE DERIVATIVES AS ALPHA-1 -ANTITRYPSIN MODULATORS FOR TREATING ALPHA-1 -ANTITRYPSIN DEFICIENCY (AATD) Vertex Pharmaceuticals Incorporated (US) 2023-02-08 EP disclosed
CN-115697969-A 7-or 8-hydroxy-isoquinoline and 7-or 8-hydroxy-quinoline derivatives as alpha-1 antitrypsin modulators for the treatment of alpha-1 antitrypsin deficiency (AATD) 弗特克斯药品有限公司 2023-02-03 CN disclosed